These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11348712)

  • 1. Detection and growth kinetics of SV40 preparations with different enhancer element copy number.
    Minor PD; Dunn G; Pipkin PA
    Vaccine; 2001 May; 19(25-26):3467-71. PubMed ID: 11348712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The archetype enhancer of simian virus 40 DNA is duplicated during virus growth in human cells and rhesus monkey kidney cells but not in green monkey kidney cells.
    O'Neill FJ; Greenlee JE; Carney H
    Virology; 2003 May; 310(1):173-82. PubMed ID: 12788641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776.
    Lednicky JA; Wong C; Butel JS
    Virus Res; 1995 Feb; 35(2):143-53. PubMed ID: 7762288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SV40 enhancer is composed of multiple functional elements that can compensate for one another.
    Herr W; Clarke J
    Cell; 1986 May; 45(3):461-70. PubMed ID: 3009027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection.
    Rizzo P; Di Resta I; Powers A; Ratner H; Carbone M
    Cancer Res; 1999 Dec; 59(24):6103-8. PubMed ID: 10626798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities.
    Ondek B; Shepard A; Herr W
    EMBO J; 1987 Apr; 6(4):1017-25. PubMed ID: 3036487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of regulatory sequences and enhancer activities of SV40 variants isolated from patients with neurological diseases.
    Martin JD; Li PN
    Virus Res; 1991 May; 19(2-3):163-72. PubMed ID: 1654014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversion of a simian virus 40 enhancer mutant depends on the growth conditions.
    Martínez-Balbás MA
    Gene; 1994 Feb; 139(2):211-4. PubMed ID: 8112606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo competition between a metallothionein regulatory element and the SV40 enhancer.
    Scholer H; Haslinger A; Heguy A; Holtgreve H; Karin M
    Science; 1986 Apr; 232(4746):76-80. PubMed ID: 3006253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of poliovirus vaccine preparations for SV40 sequences.
    Sangar D; Pipkin PA; Wood DJ; Minor PD
    Biologicals; 1999 Mar; 27(1):1-10. PubMed ID: 10441397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.
    Cutrone R; Lednicky J; Dunn G; Rizzo P; Bocchetta M; Chumakov K; Minor P; Carbone M
    Cancer Res; 2005 Nov; 65(22):10273-9. PubMed ID: 16288015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors.
    Lednicky JA; Garcea RL; Bergsagel DJ; Butel JS
    Virology; 1995 Oct; 212(2):710-7. PubMed ID: 7571441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of strains of the polyomavirus SV40 from rhesus monkey kidney cells dating from the 1950s to the early 1960s.
    Peden K; Sheng L; Omeir R; Yacobucci M; Klutch M; Laassri M; Chumakov K; Pal A; Murata H; Lewis AM
    Virology; 2008 Jan; 370(1):63-76. PubMed ID: 17900651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Viral contamination of polio vaccines in context of antivaccination mythology].
    Mats AN; Kuz'mina MN; Cheprasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):104-12. PubMed ID: 21384596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplications of a mutated simian virus 40 enhancer restore its activity.
    Herr W; Gluzman Y
    Nature; 1985 Feb 21-27; 313(6004):711-4. PubMed ID: 2983220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A purine-rich DNA sequence motif present in SV40 and lymphotropic papovavirus binds a lymphoid-specific factor and contributes to enhancer activity in lymphoid cells.
    Petterson M; Schaffner W
    Genes Dev; 1987 Nov; 1(9):962-72. PubMed ID: 2828177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mutated simian virus 40 enhancers by amplification of wild-type enhancer elements.
    Clarke J; Herr W
    J Virol; 1987 Nov; 61(11):3536-42. PubMed ID: 2822961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA.
    Sierra-Honigmann A; Krause PR
    Biologicals; 2000 Mar; 28(1):1-4. PubMed ID: 10799049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novobiocin inhibits the SV40 enhancer activity.
    Kohno K; Iwamoto Y; Martin GR; Yamada Y
    Biochem Biophys Res Commun; 1988 Jul; 154(1):483-8. PubMed ID: 2840073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sequence motifs that are involved in SV40 enhancer function also control SV40 late promoter activity.
    May E; Omilli F; Ernoult-Lange M; Zenke M; Chambon P
    Nucleic Acids Res; 1987 Mar; 15(6):2445-61. PubMed ID: 3031598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.